Evidence map›Paper›PMID 40313307›Full record

ArticlemedRxiv : the preprint server for health sciences2025

C-reactive protein for pulmonary tuberculosis screening and treatment response monitoring in children.

Joy Githua, Jerphason Mecha, Joshua Stern, Jaclyn N Escudero, Lilian Njagi, Lucy Kijaro, Jacqueline Mirera, Wilfred Murithi, Grace John-Stewart, Elizabeth Maleche-Obimbo and 2 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jerphason Mecha
Joshua Stern
Jaclyn N Escudero
Lilian Njagi
Lucy Kijaro
Jacqueline Mirera
Wilfred Murithi
Grace John-Stewart
Elizabeth Maleche-Obimbo
Videlis Nduba
Sylvia M LaCourse

Funding

Seattle Tuberculosis Research Advancement CenterP30AI168034 · NIAID · UNIVERSITY OF WASHINGTON · PI CHETAN SESHADRI · 2022 to 2026
$6.3M
Tuberculosis & HIV Co-Infection Training Program in KenyaD43TW011817 · FIC · UNIVERSITY OF WASHINGTON · PI Thomas R Hawn, VIDELIS NDUBA · 2021 to 2026
$1.6M
FIC NIH HHS D43 TW011817NIAID NIH HHS P30 AI168034
6 · The paper itself

Abstract

C-reactive protein (CRP) was investigated as a marker for diagnostic screening and monitoring response to treatment for tuberculosis (TB) in Kenyan children. For screening, CRP levels did not differ significantly between children with versus without TB. However, median CRP levels decreased significantly during TB treatment in confirmed (p=0.03) and unconfirmed TB (p=0.002) suggesting potential of treatment response monitoring. SUMMARY: CRP levels did not differ significantly between children with versus without TB at diagnosis but decreased significantly during TB treatment in confirmed (p=0.02) and unconfirmed TB (p<0.001). While CRP's diagnostic screening performance was suboptimal, findings suggest potential utility for treatment response monitoring in children with TB.

Identifiers

PMID40313307
PMCPMC12045435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.